|Bid||12.22 x 200|
|Ask||12.23 x 100|
|Day's Range||11.78 - 12.28|
|52 Week Range||4.95 - 12.40|
|PE Ratio (TTM)||112.39|
|Earnings Date||Jul 31, 2017 - Aug 4, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||11.00|
A Relative Strength Rating upgrade for Ionis Pharmaceuticals shows improving technical performance. Will it continue?
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Corcept Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CORT-US. Comparing the performance and risk of Corcept Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Upcoming AWS Coverage on Corcept Therapeutics Post-Earnings Results LONDON, UK / ACCESSWIRE / May 12, 2017 / Active Wall St. blog coverage looks at the headline from Synthetic Biologics, Inc. (NYSE: SYN ...